This board can be very addictive. Hearing others t
Post# of 148015
I know some on this board say that management should put out more news so that they can attract new investors. The thought is that would drive up the share price. We’ve seen in the past a rise following a PR with a subsequent drop not much later. Plus, new investors buying at 13 cent will very likely cash out when it hits $1. It’s easy to say “I’m up 700-800%. That’s good enough for me. I’m out of here.” Likely scenario if they’re not well versed in the potential of the molecule.
I believe the long suffering investors, especially the ones who have been here from beginning days of CytoDyn, are more important to the ultimate value of this stock. Anyone who bought the stock in its heyday when it was $5, $6, $7, and have been buying more recently to bring their average purchase price down to maybe $2 or $1 is unlikely to unload at a modest stock rise.
What is important is belief in the molecule and belief that management will make the right decisions to maximize share value. There might be some long time investors selling a few shares along the way. Watching the price rise to $10 and fall to 13 cents, the earliest investors might be thinking I’m not going to let it happen again. So there may be some resistance as the stock price rises. But this time things are different. Ultimately, the molecule will show its worth, and good management is in place.
Do your own due diligence and continue to buy if you truly believe. As someone said, it’s only a paper loss unless you sell.